Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL

Jennifer A. Woyach, Gabriela Perez Burbano, Amy S. Ruppert, Cecelia Miller, Nyla A. Heerema, Weiqiang Zhao, Anna Wall, Wei Ding, Nancy L. Bartlett, Danielle M. Brander, Paul M. Barr, Kerry A. Rogers, Sameer A. Parikh, Deborah M. Stephens, Jennifer R. Brown, Gerard Lozanski, James Blachly, Sreenivasa Nattam, Richard A. Larson, Harry ErbaMark Litzow, Selina Luger, Carolyn Owen, Charles Kuzma, Jeremy S. Abramson, Richard F. Little, Shira Dinner, Richard M. Stone, Geoffrey Uy, Wendy Stock, Sumithra J. Mandrekar, John C. Byrd

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds